Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Modeling intraocular bacterial infections.

Tytuł:
Modeling intraocular bacterial infections.
Autorzy:
Astley RA; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Coburn PS; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Parkunan SM; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Callegan MC; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Dean McGee Eye Institute, Oklahoma City, OK, USA. Electronic address: .
Źródło:
Progress in retinal and eye research [Prog Retin Eye Res] 2016 Sep; Vol. 54, pp. 30-48. Date of Electronic Publication: 2016 May 03.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Oxford : Pergamon
Original Publication: Oxford ; New York : Pergamon Press c1994-
MeSH Terms:
Disease Models, Animal*
Endophthalmitis/*microbiology
Eye Infections, Bacterial/*microbiology
Animals ; Anti-Bacterial Agents/therapeutic use ; Endophthalmitis/drug therapy ; Eye Infections, Bacterial/drug therapy ; Glucocorticoids/therapeutic use ; Humans ; Vitrectomy
References:
Clin Ophthalmol. 2013;7:247-52. (PMID: 23403798)
Surv Ophthalmol. 1982 Jan-Feb;26(4):204-6. (PMID: 6978542)
Ocul Immunol Inflamm. 2017 Feb;25(1):111-121. (PMID: 26679534)
Clin Ophthalmol. 2008 Mar;2(1):139-45. (PMID: 19668397)
Retina. 1997;17(6):521-9. (PMID: 9428015)
Trans Am Ophthalmol Soc. 1947;45:570-636. (PMID: 16693463)
Trans Am Ophthalmol Soc. 2004;102:305-20. (PMID: 15747765)
Ophthalmology. 2007 Apr;114(4):686-91. (PMID: 17184840)
Retina. 2002 Oct;22(5):622-32. (PMID: 12441729)
Infect Immun. 2013 Jun;81(6):2217-25. (PMID: 23569113)
Pharmacotherapy. 2007 Dec;27(12):1711-21. (PMID: 18041891)
Arch Ophthalmol. 1986 Mar;104(3):367-71. (PMID: 3485422)
Surv Ophthalmol. 1999 Nov-Dec;44(3):215-25. (PMID: 10588440)
Arch Ophthalmol. 1995 Dec;113(12):1555-7. (PMID: 7487626)
Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):913-7. (PMID: 19280208)
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3233-8. (PMID: 16123424)
Prog Retin Eye Res. 2014 Sep;42:27-43. (PMID: 24819336)
Ophthalmic Res. 2015;53(3):149-61. (PMID: 25791614)
Doc Ophthalmol. 1975 Nov 21;39(1):183-201. (PMID: 1081447)
J Cataract Refract Surg. 2008 Sep;34(9):1460-7. (PMID: 18721704)
Int Ophthalmol Clin. 1987 Summer;27(2):112-9. (PMID: 3294703)
Bull World Health Organ. 2001;79(3):249-56. (PMID: 11285671)
Prog Retin Eye Res. 2012 Jul;31(4):316-31. (PMID: 22521570)
Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1029-36. (PMID: 14618340)
Invest Ophthalmol Vis Sci. 2011 May 16;52(6):3187-92. (PMID: 21345983)
Br J Ophthalmol. 2008 Apr;92(4):466-8. (PMID: 18369061)
Arch Ophthalmol. 2005 May;123(5):649-53. (PMID: 15883284)
Am J Ophthalmol. 1959 Nov;48(5)Pt 2:435-47. (PMID: 14446781)
Arch Ophthalmol. 1990 Jun;108(6):857-60. (PMID: 2350288)
Int J Med Microbiol. 2010 Aug;300(6):357-62. (PMID: 20452280)
Retina. 1998;18(2):130-5. (PMID: 9564693)
Curr Eye Res. 1997 Oct;16(10):1036-43. (PMID: 9330856)
Curr Eye Res. 2014 Aug;39(8):790-802. (PMID: 24588082)
Am J Ophthalmol. 1996 Nov;122(5):678-83. (PMID: 8909207)
Arch Ophthalmol. 1976 Dec;94(12):2078-81. (PMID: 1087148)
Infect Immun. 2003 Jun;71(6):3116-24. (PMID: 12761089)
J Ocul Pharmacol Ther. 2012 Dec;28(6):604-8. (PMID: 22925112)
Jpn J Infect Dis. 2007 Feb;60(1):33-9. (PMID: 17314423)
Int J Pharm. 2000 Aug 25;204(1-2):91-5. (PMID: 11011990)
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975 Aug 4;196(1):85-94. (PMID: 1080641)
Infect Immun. 1997 Apr;65(4):1550-6. (PMID: 9119503)
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):667-74. (PMID: 19039600)
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2479-86. (PMID: 15980239)
Arch Ophthalmol. 1999 Apr;117(4):520-1. (PMID: 10206582)
Am J Ophthalmol. 2006 Nov;142(5):721-5. (PMID: 16989762)
Infect Immun. 2002 Aug;70(8):4678-81. (PMID: 12117982)
Antimicrob Agents Chemother. 2000 Dec;44(12):3249-56. (PMID: 11083623)
Jpn J Ophthalmol. 2008 May-Jun;52(3):211-216. (PMID: 18661272)
Arch Ophthalmol. 1984 Apr;102(4):547-50. (PMID: 6704010)
Arch Ophthal. 1945 Sep;34:195-201. (PMID: 21004333)
Arch Ophthalmol. 1999 Aug;117(8):1058-62. (PMID: 10448749)
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1109-12. (PMID: 16505048)
Infect Immun. 1995 Feb;63(2):632-9. (PMID: 7822032)
Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1322-8. (PMID: 16544114)
J Ophthalmol. 2015;2015:261310. (PMID: 25802752)
Graefes Arch Clin Exp Ophthalmol. 2003 Jun;241(6):478-83. (PMID: 12756578)
Infect Immun. 1992 Jun;60(6):2445-52. (PMID: 1587612)
J Ocul Pharmacol Ther. 2010 Dec;26(6):571-7. (PMID: 21034245)
J Infect Dis. 1997 Feb;175(2):462-6. (PMID: 9203674)
Invest Ophthalmol Vis Sci. 2015 Feb 12;56(3):1719-32. (PMID: 25678692)
Am J Ophthalmol. 2004 Jul;138(1):33-7. (PMID: 15234279)
Ophthalmology. 2004 Aug;111(8):1495-503; discussion 1503. (PMID: 15288977)
Prog Retin Eye Res. 2009 Mar;28(2):117-44. (PMID: 19114125)
Arch Ophthalmol. 2012 Dec;130(12):1617-8. (PMID: 23229711)
Invest Ophthalmol Vis Sci. 1992 Apr;33(5):1650-6. (PMID: 1559764)
Ophthalmology. 2000 Mar;107(3):486-9. (PMID: 10711885)
Ophthalmology. 2009 Jun;116(6):1225.e1. (PMID: 19486799)
Arch Ophthal. 1946 Jan;35:33-8. (PMID: 21014037)
Int Ophthalmol. 2011 Feb;31(1):29-31. (PMID: 20661624)
Prog Retin Eye Res. 2010 Nov;29(6):596-609. (PMID: 20826225)
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1026-32. (PMID: 8125713)
Clin Infect Dis. 2004 May 15;38 Suppl 4:S357-62. (PMID: 15127370)
Infect Immun. 1999 Jul;67(7):3357-66. (PMID: 10377113)
Arch Ophthalmol. 2006 Apr;124(4):479-83. (PMID: 16606872)
Am J Ophthalmol. 1946 May;29:599-601. (PMID: 21027019)
J Endocrinol. 2003 Nov;179(2):139-44. (PMID: 14596665)
Int Ophthalmol Clin. 2014 Spring;54(2):215-24. (PMID: 24613894)
Clin Infect Dis. 2004 Jun 1;38(11):1564-9. (PMID: 15156444)
Eye (Lond). 2013 Mar;27(3):450-2. (PMID: 23306728)
J Cataract Refract Surg. 2007 Jun;33(6):978-88. (PMID: 17531690)
Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):313-20. (PMID: 14986007)
Curr Eye Res. 2009 Feb;34(2):145-51. (PMID: 19219686)
Diagn Microbiol Infect Dis. 2006 Sep;56(1):63-8. (PMID: 16650951)
Retina. 2006 Jul-Aug;26(6 Suppl):S47-50. (PMID: 16832300)
Arch Ophthalmol. 1994 Jan;112(1):48-53. (PMID: 8285892)
Adv Ther. 2008 Oct;25(10):979-94. (PMID: 18836691)
J Antimicrob Chemother. 1981 Sep;8 Suppl B:23-31. (PMID: 19802967)
J Pathol. 1986 Dec;150(4):257-65. (PMID: 3806283)
Infect Immun. 1999 Jul;67(7):3348-56. (PMID: 10377112)
Tohoku J Exp Med. 2005 Mar;205(3):223-9. (PMID: 15718814)
Ophthalmology. 2003 Aug;110(8):1560-6. (PMID: 12917173)
Ocul Immunol Inflamm. 2004 Sep;12(3):169-92. (PMID: 15385194)
Surv Ophthalmol. 1997 Mar-Apr;41(5):395-401. (PMID: 9163836)
Ophthalmology. 2005 Aug;112(8):1388-94. (PMID: 15953637)
Prog Retin Eye Res. 2015 Sep;48:137-59. (PMID: 25936606)
Ophthalmology. 1999 Sep;106(9):1665-70. (PMID: 10485532)
Arch Ophthalmol. 2004 Oct;122(10):1499-506. (PMID: 15477462)
Am J Ophthalmol. 2004 Jan;137(1):38-42. (PMID: 14700642)
J Ocul Pharmacol Ther. 2013 Apr;29(3):339-44. (PMID: 23289847)
Curr Eye Res. 2006 Mar;31(3):225-30. (PMID: 16531279)
Retina. 1997;17(1):28-32. (PMID: 9051839)
Surv Ophthalmol. 2014 Nov-Dec;59(6):627-35. (PMID: 25113611)
Infect Immun. 2002 Oct;70(10):5381-9. (PMID: 12228262)
Prog Retin Eye Res. 2010 Sep;29(5):376-97. (PMID: 20452457)
Acta Ophthalmol Scand. 2007 Dec;85(8):852-6. (PMID: 17725616)
Eye (Lond). 1998;12 ( Pt 6):910-5. (PMID: 10325984)
Ophthalmology. 2000 Aug;107(8):1483-91. (PMID: 10919895)
Intern Med J. 2011 Jun;41(6):441-9. (PMID: 21309997)
Clin Infect Dis. 2004 May 15;38 Suppl 4:S350-6. (PMID: 15127369)
Br J Ophthalmol. 1999 Sep;83(9):1050-5. (PMID: 10460774)
Curr Eye Res. 2007 Apr;32(4):337-44. (PMID: 17453955)
Vision Res. 1985;25(1):21-31. (PMID: 3984214)
Br J Ophthalmol. 1996 Aug;80(8):755-8. (PMID: 8949723)
Arch Ophthalmol. 1974 Aug;92(2):149-54. (PMID: 4211214)
Br J Ophthalmol. 2011 Oct;95(10):1385-8. (PMID: 21289020)
Surv Ophthalmol. 2011 May-Jun;56(3):214-51. (PMID: 21397289)
PLoS One. 2014 Jun 24;9(6):e100543. (PMID: 24959742)
Br J Ophthalmol. 2016 Apr;100(4):446-52. (PMID: 26701686)
Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2785-90. (PMID: 9856792)
Curr Eye Res. 2006 Nov;31(11):955-65. (PMID: 17114121)
Mol Cell Endocrinol. 2011 Mar 15;335(1):2-13. (PMID: 20398732)
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1480-7. (PMID: 18385066)
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4482-9. (PMID: 18586878)
Retina. 1999;19(3):218-22. (PMID: 10380027)
Curr Opin Ophthalmol. 2010 May;21(3):178-83. (PMID: 20375895)
Antimicrob Agents Chemother. 1999 Apr;43(4):727-37. (PMID: 10103173)
Retina. 2009 May;29(5):601-5. (PMID: 19357558)
Arch Ophthalmol. 1995 Oct;113(10):1324-9. (PMID: 7575268)
J Infect Dis. 2010 Jan 15;201(2):255-63. (PMID: 19995266)
Curr Eye Res. 2004 Oct-Nov;29(4-5):253-9. (PMID: 15590470)
Inflamm Res. 2012 Mar;61(3):225-31. (PMID: 22119862)
Infect Immun. 2008 Apr;76(4):1781-90. (PMID: 18227158)
Am J Ophthalmol. 1955 Jul;40(1):86-101. (PMID: 14388099)
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3783-93. (PMID: 19264886)
Clin Ophthalmol. 2008 Dec;2(4):793-800. (PMID: 19668433)
Trans Am Ophthalmol Soc. 1996;94:241-52; discussion 252-7. (PMID: 8981699)
Arch Ophthalmol. 2005 May;123(5):613-20. (PMID: 15883279)
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4461-7. (PMID: 17003440)
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4931-8. (PMID: 18586871)
PLoS One. 2011;6(12):e28619. (PMID: 22163046)
PLoS One. 2014 Oct 23;9(10):e110872. (PMID: 25340474)
Arch Ophthalmol. 1989 Jan;107(1):107-12. (PMID: 2910268)
Curr Eye Res. 2001 Jun;22(6):451-7. (PMID: 11584345)
Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):865-72. (PMID: 21051708)
Infect Immun. 2015 Oct;83(10):3926-36. (PMID: 26195555)
J Ocul Pharmacol Ther. 2011 Dec;27(6):593-8. (PMID: 21834669)
Retina. 2009 Jul-Aug;29(7):875-912. (PMID: 19584648)
Invest Ophthalmol Vis Sci. 2012 Nov 01;53(12):7426-31. (PMID: 23036996)
Invest Ophthalmol Vis Sci. 2014 Apr 15;55(4):2392-402. (PMID: 24644055)
Ophthalmology. 2006 Jun;113(6):992-1001.e6. (PMID: 16647134)
AMA Arch Ophthalmol. 1952 Dec;48(6):738-46. (PMID: 12984911)
Prog Retin Eye Res. 2012 Mar;31(2):182-94. (PMID: 22120610)
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3077-82. (PMID: 12824254)
Can J Ophthalmol. 1977 Oct;12(4):304-7. (PMID: 336163)
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1200-5. (PMID: 16235062)
Br J Ophthalmol. 1988 Apr;72(4):309-12. (PMID: 3259895)
Curr Clin Pharmacol. 2010 Feb;5(1):47-54. (PMID: 20236082)
Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1828-36. (PMID: 7635657)
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12. (PMID: 23401516)
Clin Microbiol Rev. 2002 Jan;15(1):111-24. (PMID: 11781270)
Ophthalmology. 2005 Jul;112(7):1199-206. (PMID: 15921759)
J Clin Microbiol. 2013 Sep;51(9):2959-63. (PMID: 23824766)
Int J Retina Vitreous. 2015 Jul 21;1:9. (PMID: 27847602)
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1974;191(2):93-107. (PMID: 4215336)
Invest Ophthalmol Vis Sci. 1985 Sep;26(9):1262-6. (PMID: 4030253)
Prog Retin Eye Res. 2007 Mar;26(2):189-203. (PMID: 17236804)
Curr Eye Res. 2010 Jun;35(6):480-6. (PMID: 20465441)
Arch Ophthalmol. 1987 Dec;105(12):1699-702. (PMID: 3500702)
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1197-9. (PMID: 16136321)
Br J Ophthalmol. 1985 Nov;69(11):841-6. (PMID: 3877524)
J Med Microbiol. 2013 Oct;62(Pt 10):1506-1516. (PMID: 23813275)
J Ocul Pharmacol Ther. 2013 May;29(4):403-9. (PMID: 23249386)
Invest Ophthalmol Vis Sci. 2011 Aug 29;52(9):6860-6. (PMID: 21791595)
Retina. 2007 Jul-Aug;27(6):662-80. (PMID: 17621174)
Invest Ophthalmol Vis Sci. 2000 Jan;41(1):145-53. (PMID: 10634614)
Bacteriophage. 2011 Jul 1;1(4):188-194. (PMID: 23050211)
PLoS One. 2015 Jun 08;10(6):e0128423. (PMID: 26053426)
Immunity. 2016 Apr 19;44(4):833-46. (PMID: 27037191)
Ophthalmology. 2014 Aug;121(8):1634-42. (PMID: 24702755)
Retina. 2011 Sep;31(8):1518-24. (PMID: 21606892)
Infect Immun. 2004 Jun;72(6):3628-33. (PMID: 15155673)
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7303-11. (PMID: 26559476)
Retina. 1997;17(2):139-45. (PMID: 9143043)
Am J Ophthalmol. 2014 Nov;158(5):1018-23. (PMID: 25089354)
Korean J Ophthalmol. 1996 Jun;10(1):8-17. (PMID: 8755196)
Infect Immun. 2000 Sep;68(9):5269-76. (PMID: 10948154)
Can J Ophthalmol. 2009 Feb;44(1):88-94. (PMID: 19169320)
Invest Ophthalmol Vis Sci. 1995 Jan;36(1):9-15. (PMID: 7822163)
Trans Am Ophthalmol Soc. 1992;90:505-59. (PMID: 1494833)
Ophthalmology. 1993 Apr;100(4):447-51. (PMID: 8479698)
Arch Ophthalmol. 1972 Dec;88(6):647-9. (PMID: 4628564)
Grant Information:
P30 EY021725 United States EY NEI NIH HHS; R01 EY012985 United States EY NEI NIH HHS; R01 EY024140 United States EY NEI NIH HHS; R21 EY022466 United States EY NEI NIH HHS
Contributed Indexing:
Keywords: Antibiotics; Bacteria; Corticosteroids; Endophthalmitis; Inflammation; Therapeutics; Vitrectomy
Substance Nomenclature:
0 (Anti-Bacterial Agents)
0 (Glucocorticoids)
Entry Date(s):
Date Created: 20160508 Date Completed: 20180108 Latest Revision: 20240325
Update Code:
20240325
PubMed Central ID:
PMC4992594
DOI:
10.1016/j.preteyeres.2016.04.007
PMID:
27154427
Czasopismo naukowe
Bacterial endophthalmitis is an infection and inflammation of the posterior segment of the eye which can result in significant loss of visual acuity. Even with prompt antibiotic, anti-inflammatory and surgical intervention, vision and even the eye itself may be lost. For the past century, experimental animal models have been used to examine various aspects of the pathogenesis and pathophysiology of bacterial endophthalmitis, to further the development of anti-inflammatory treatment strategies, and to evaluate the pharmacokinetics and efficacies of antibiotics. Experimental models allow independent control of many parameters of infection and facilitate systematic examination of infection outcomes. While no single animal model perfectly reproduces the human pathology of bacterial endophthalmitis, investigators have successfully used these models to understand the infectious process and the host response, and have provided new information regarding therapeutic options for the treatment of bacterial endophthalmitis. This review highlights experimental animal models of endophthalmitis and correlates this information with the clinical setting. The goal is to identify knowledge gaps that may be addressed in future experimental and clinical studies focused on improvements in the therapeutic preservation of vision during and after this disease.
(Copyright © 2016 Elsevier Ltd. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies